PRS9 THE COST-EFFECTIVENESS OF TARGETED PRESCRIBING OF ANTIMICROBIALS IN CANADA FOR COMMUNITY-ACQUIRED PNEUMONIA IN AN ERA OF ANTIMICROBIAL RESISTANCE
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70857-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70857-3/fulltext
Section Title :
Section Order :
612
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70857-3&doi=10.1016/S1098-3015(10)70857-3